Trial Profile
A Randomised Controlled Trial of Bisphosphonate Therapy in Osteonecrosis of the Hip.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Femur head necrosis
- Focus Therapeutic Use
- Acronyms BONES
- 17 Jan 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 26 Mar 2010 Alendronate deleted as drug descriptor as reported by ClinicalTrials.gov.
- 26 Mar 2010 Planned number of patients changed from 150 to 120 as reported by ClinicalTrials.gov.